A surprisingly large amount of non-aspirin nonsteroidal anti-inflammatory drug (NAN-SAID) usage occurs in the United States, with estimates of as many as 30 billion tablets consumed per year.

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

GammaCore could be a novel alternative to electronic aspirin. It is a non-surgical US Food and Drug Administration (FDA) ...